Latka logo

2021 Revenue

$41.5K

Team

1

Founded

2018

Yaobianli Revenue (2021)

Yaobianli generated $41.5K in revenue in 2021.

Developer of an SaaS mobile application designed to provide medicine around the clock. The application acts as a drug store chain operating and helps pharmacies provide a 24 hour service in which people in need of medicine can access it even when traditional brick and mortar pharmacies are closed enabling customers to get medicine when needed. The company's application also provides informational videos on more than 1000 different drugs, provides data analysis for pharmacies on customer data and promotes popular drug products enabling users to understand the drug's usage in detail and whether it is appropriate for consumption.

Last updated

Yaobianli Revenue

In 2021, Yaobianli's revenue reached $41.5K.

Yaobianli Revenue GrowthReported revenue / ARR over time$0$10K$20K$30K$40K$50K2018201920202021$0$41.5KSource: GetLatka.com
YearMilestoneSource
2021Yaobianli Hit $41.5k revenue in April 2021Not recorded
2018Launched with $0 revenue

Founder / CEO

Yaobianli Employees & Team Size

Yaobianli employs approximately 1 people as of 2026.

Yaobianli Team GrowthReported headcount over time00111120182019202020210011Source: GetLatka.com
YearMilestoneSource
2021Reached 1 employees (April 2021)Not recorded

Frequently Asked Questions about Yaobianli

Is Yaobianli still operating?

No. Yaobianli has shut down.

What is Yaobianli's revenue?

As of 2021, Yaobianli generated $41.5K in revenue.

Who founded Yaobianli?

Yaobianli was founded by Xiaopeng He.

When was Yaobianli founded?

Yaobianli was founded in 2018.

How many employees does Yaobianli have?

As of 2021, Yaobianli had 1 employees.

Where is Yaobianli headquartered?

Yaobianli is headquartered in China.

Compare Yaobianli to the industry

Yaobianli operates across multiple industries. Browse revenue, funding, and growth data for Yaobianli in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile